Status:
COMPLETED
Rapid Point-of-care Testing for Hepatitis C in Community Clinics (RAPID-EC) Pilot Study
Lead Sponsor:
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
Collaborating Sponsors:
Gilead Sciences
Conditions:
Hepatitis C
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The Rapid-EC pilot study will determine feasibility of providing rapid point-of-care (POC) testing for HCV in community clinics, and whether the availability of POC testing increases uptake of testing...
Detailed Description
The introduction of direct-acting antiviral (DAA) therapies has meant the elimination of hepatitis C (HCV) as a public health issue in Australia is a very real possibility. The challenge that remains ...
Eligibility Criteria
Inclusion
- Aged ≥18 years;
- Attendance for any reason at either the primary health care services participating in the study
- Not currently engaged in care for treatment of hepatitis C infection, and not received a diagnosis of hepatitis C infection (with positive HCV RNA) in the preceding 3 months;
Exclusion
- Pregnancy or breastfeeding at time of HCV antiviral treatment;
- Evidence of any condition, therapy, laboratory abnormality or other circumstance (current or prior) that may confound the study's results, or interfere with participation for the full duration of the study, such that it is not in the best interest of the participant.
Key Trial Info
Start Date :
June 29 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 17 2018
Estimated Enrollment :
174 Patients enrolled
Trial Details
Trial ID
NCT03231930
Start Date
June 29 2017
End Date
May 17 2018
Last Update
July 15 2019
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Innerspace
Collingwood, Victoria, Australia, 3066
2
Health Works
Footscray, Victoria, Australia, 3011
3
North Richmond Community Health
Richmond, Victoria, Australia, 3121